Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

BUY
$229.03 - $291.01 $182,307 - $231,643
796 New
796 $209,000
Q4 2020

Feb 02, 2021

SELL
$216.38 - $257.67 $197,987 - $235,768
-915 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$234.65 - $260.95 $11,732 - $13,047
50 Added 5.78%
915 $232,000
Q2 2020

Aug 04, 2020

BUY
$197.81 - $242.74 $171,105 - $209,970
865 New
865 $204,000
Q1 2020

Apr 24, 2020

SELL
$182.24 - $241.7 $157,455 - $208,828
-864 Closed
0 $0
Q4 2019

Mar 16, 2020

BUY
$189.21 - $243.2 $163,477 - $210,124
864 New
864 $208,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tfg Advisers LLC Portfolio

Follow Tfg Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Advisers LLC with notifications on news.